BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29525671)

  • 21. Recombinant Chinese Hu191 measles virus exhibits a significant antitumor activity against nephroblastoma mediated by immunogenic form of apoptosis.
    Zhu M; Wang Y; Qu C; Liu R; Zhang C; Wang J; Zhou D; Gu W; Chen P; Wu B; Zhao Z
    Am J Transl Res; 2021; 13(4):2077-2093. PubMed ID: 34017376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A recombinant Chinese measles virus vaccine strain rMV-Hu191 inhibits human colorectal cancer growth through inducing autophagy and apoptosis regulating by PI3K/AKT pathway.
    Zhang CD; Wang YL; Zhou DM; Zhu MY; Lv Y; Hao XQ; Qu CF; Chen Y; Gu WZ; Wu BQ; Chen PC; Zhao ZY
    Transl Oncol; 2021 Jul; 14(7):101091. PubMed ID: 33848808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
    Julik E; Reyes-Del Valle J
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector.
    Tangy F; Naim HY
    Viral Immunol; 2005; 18(2):317-26. PubMed ID: 16035943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
    Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
    Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys.
    Fujiyuki T; Horie R; Yoneda M; Kuraishi T; Yasui F; Kwon HJ; Munekata K; Ikeda F; Hoshi M; Kiso Y; Omi M; Sato H; Kida H; Hattori S; Kohara M; Kai C
    Sci Rep; 2017 Sep; 7(1):12017. PubMed ID: 28931922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.
    Baldo A; Galanis E; Tangy F; Herman P
    Hum Vaccin Immunother; 2016 May; 12(5):1102-16. PubMed ID: 26631840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys.
    Devaux P; Hudacek AW; Hodge G; Reyes-Del Valle J; McChesney MB; Cattaneo R
    J Virol; 2011 Jan; 85(1):348-56. PubMed ID: 20980517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
    Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
    Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 36. An immune competent mouse model for the characterization of recombinant measles vaccines.
    Marty RR; Knuchel MC; Morin TN; Naim HY
    Hum Vaccin Immunother; 2015; 11(1):83-90. PubMed ID: 25483519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dry powder measles vaccine: particle deposition, virus replication, and immune response in cotton rats following inhalation.
    Kisich KO; Higgins MP; Park I; Cape SP; Lindsay L; Bennett DJ; Winston S; Searles J; Sievers RE
    Vaccine; 2011 Jan; 29(5):905-12. PubMed ID: 20974303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of measles vaccine in the throat of a vaccinated child.
    Morfin F; Beguin A; Lina B; Thouvenot D
    Vaccine; 2002 Feb; 20(11-12):1541-3. PubMed ID: 11858860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant measles virus vaccine rMV-Hu191 exerts an oncolytic effect on esophageal squamous cell carcinoma via caspase-3/GSDME-mediated pyroptosis.
    Wu A; Li Z; Wang Y; Chen Y; Peng J; Zhu M; Li Y; Song H; Zhou D; Zhang C; Lv Y; Zhao Z
    Cell Death Discov; 2023 May; 9(1):171. PubMed ID: 37202386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.
    Mura M; Combredet C; Najburg V; Sanchez David RY; Tangy F; Komarova AV
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.